Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Controlled, Multi-Center, Post-Approval Trial to Evaluate the Long-term Safety and Effectiveness of AUGMENT® Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Foot and Ankle Fusions

NCT02879149 is registered in ClinicalTrials.gov with BioMimetic Therapeutics as lead sponsor.

NCT NCT02879149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02879149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Controlled, Multi-Center, Post-Approval Trial to Evaluate the Long-term Safety and Effectiveness of AUGMENT® Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Foot and Ankle Fusions
Lead sponsor
BioMimetic Therapeutics
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2016
Completion date
December 31, 2018
Enrollment
150 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

ankle and hindfoot arthrodesis